NV Therapeutics develops Non-Viral gene editing technology to revolutionize cell and gene therapies.
NV Therapeutics has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
NV Therapeutics is headquartered in Berkeley, United States.
NV Therapeutics develops Non-Viral gene editing technology to revolutionize cell and gene therapies.
NV Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NV Therapeutics — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/nv-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). NV Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nv-therapeutics
{{cite web |title=NV Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nv-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated